back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-09 18:24 Tx date 2026-03-08 |
$ONCY
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-45,000 vol |
747,994 | |
| Filed 2026-02-13 09:47 Tx date 2026-02-12 |
$ONCY
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$8,298
+10,000 vol $0.83 each |
79,842 | |
| Filed 2025-12-19 18:17 Tx date 2025-12-15 |
$ONCY
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$247,500
+250,000 vol $0.99 each |
792,994 | |
| Filed 2025-12-11 18:11 Tx date 2025-12-10 |
$ONCY
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-55,000 vol |
542,994 | |
| Filed 2025-12-10 18:07 Tx date 2025-12-09 |
$ONCY
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-5,263 vol |
597,994 | |
| Filed 2025-08-22 18:13 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$259,200
+240,000 vol $1.08 each |
603,257 | |
| Filed 2025-08-18 19:00 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,967 vol |
69,842 | |
| Filed 2025-08-18 18:57 Tx date 2025-08-18 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,967 vol |
35,217 | |
| Filed 2025-07-18 09:04 Tx date 2025-07-17 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,866
+4,600 vol $1.71 each |
67,875 | |
| Filed 2025-01-29 13:29 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+50,609 vol |
63,275 | |
| Filed 2025-01-29 12:39 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+50,609 vol |
||
| Filed 2025-01-29 12:39 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+50,609 vol |
63,275 | |
| Filed 2025-01-29 12:38 Tx date 2025-01-29 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-74,910 vol |
37,184 | |
| Filed 2024-12-20 17:16 Tx date 2024-12-18 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+95,160 vol |
112,094 | |
| Filed 2024-12-20 17:15 Tx date 2024-12-18 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$85,427
+75,600 vol $1.13 each |
363,257 | |
| Filed 2024-12-12 09:52 Tx date 2024-12-09 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+6,500 vol |
12,666 | |
| Filed 2024-12-12 09:50 Tx date 2024-12-09 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-6,500 vol |
16,934 | |
| Filed 2024-12-12 09:48 Tx date 2024-12-11 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-202,421 vol |
287,657 | |
| Filed 2024-11-28 10:13 Tx date 2024-11-27 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$3,865,156
+1,966 vol $1,966 each |
6,166 | |
| Filed 2024-11-28 10:11 Tx date 2024-11-27 |
$ONC
Oncolytics Biotech Inc. |
Hagerman, Allison
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-1,966 vol |
23,434 |